Across TCGA pan-cancer cohorts, ANKRD20A5P Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated ANKRD20A5P data layer compared with 24 for mass-spec protein.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher ANKRD20A5P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated ANKRD20A5P expression acts as an unfavorable survival marker.

ESCA, LGG, and SKCM are the cancer types where ANKRD20A5P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Median	II,III,IV	0.103	0.868	<.001	15	view →
LGG	DFS	Median	All	0.185	0.826	<.001	6	view →
SKCM	OS	Median	III,IV	0.216	0.705	.010	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: ANKRD20A5P tumor-vs-normal RNA expression · all ANKRD20A5P data types